Background Diagnosing tuberculosis (TB) in children is difficult. Typical methods take a long time to achieve results, or have a low sensitivity. GeneXpert is a nucleic acid amplification test used to identify Mycobacterium tuberculosis bacteria (MTB) in only 2 hours.
T uberculosis remains a major problem worldwide. In 2013, 9 million people developed TB and 1.5 million people died from the disease. 1 Every year, TB in children accounts for at least 6% of the global burden of disease. These numbers (530,000-999,792 cases) underestimate the burden of childhood TB, which is higher due to difficulty in diagnosing childhood tuberculosis, emphasizing the need for improved diagnostics. 2 Tuberculosis in children manifests with severe dissemination and clinical presentations. In this age group, hematogenous and lymphatic spread of the primary infection cause extrapulmonary symptoms such as miliary and meningitic disease. Young children with severe and complicated disease have a much higher mortality rate than adults. 2 Tuberculosis is among the 10 major causes of mortality among children, with a global estimate of 130,000 deaths per year. 3 In children, culture methods have a greater, yet highly variable, sensitivity than other typical diagnostic methods. For this reason, microbiological confirmation of childhood tuberculosis is rarely performed, and clinical diagnosis relies on a combination of signs, symptoms, radiological findings, and identification of a tuberculosis contact. 4 Newer tools such as nucleic acid amplification tests have a slightly higher sensitivity of 40-60%. Other diagnostic tests, including the tuberculin skin test and the interferon gamma release assay, are limited in differentiating between latent infection and active disease. 5 There is an urgent need for a rapid, sensitive, and specific test for tuberculosis and for identification of drug-resistant disease in children. 6 The recent innovation of the Xpert MTB/RIF test by Cephedi (Sunnyvale, CA, USA) has greatly transformed the field of TB diagnostics. The Xpert MTB/RIF test simultaneously detects Mycobacterium tuberculosis (MTB) and resistance to rifampicin using real-time polymerase chain reaction (PCR) analysis, and produces results within 2 hours. The other main advantage of the Xpert MTB/RIF compared to traditional PCR methods is that it is fully automated. 7 In the 2011 policy statement on the Xpert MTB/ RIF test, the World Health Organisation (WHO) recommended the test as an initial diagnostic tool among children with suspected HIV-associated TB or multi-drug resistant (MDR) TB, based on successful data in adults. 8 There has been limited published data on the utility of the Xpert MTB/RIF test in the pediatric population with tuberculosis. Nicol et al. found an overall sensitivity of 100% for smearpositive/culture-positive cases, 61.1% for smearnegative/culture-positive, and specificity of 98.8% when two induced sputum samples were assessed in children aged less than 15 years with suspected pulmonary tuberculosis in Cape Town, South Africa. 6 Statistical guidance on reporting results from studies evaluating diagnostic tests was used to calculate sensitivity and specificity of the assay and value of agreement with Kappa scores. 9 Sekadde et al. in Uganda described clinical characteristics associated with a positive Xpert MTB test. The clinical characteristics which were independently associated with a positive Xpert MTB test included age > 5 years, a positive history of TB contact, and a positive tuberculin test. 7 The aim of this study was to assess the sensitivity, specificity, and agreement of the GeneXpert MTB test to MTB culture as the gold standard for the diagnosis of childhood tuberculosis in Hasan Sadikin Hospital and describe factors associated with positive GeneXpert MTB test results.
Methods
This descriptive, analytical study with cross-sectional design, was done with data collected from medical records of children with TB from January 2016 until December 2017 at Hasan Sadikin Hospital, Bandung, West Java, Indonesia. The study inclusion criteria were inpatients and outpatients in Hasan Sadikin Hospital aged 1 month until 18 years, diagnosed with suspected TB based on the WHO case definition for a TB suspect ,10,11 who underwent MTB culture and GeneXpert testing, and had complete medical records. We excluded patients with incomplete medical records. The study forms were filled in based on secondary data from medical records.
All statistical analyses were performed using the SPSS software (version 15.0). Chi-square test was done to analyze for associations with positive GeneXpert test results. Results with P value less than 0.25 were analyzed by multivariate logistic regression; and P values less than 0.05 were considered to be statistically significant. Sensitivity and specificity were calculated for the diagnostic test. Kappa analysis was used to determine agreement between GeneXpert MTB and solid MTB culture as the gold standard. Following conversion, four levels of agreement for Kappa were reported: <0.40 (poor), 0.40-0.59 (fair), 0.60-0.80 (good), and >0.80 (excellent). 12, 13 The study was approved by the Research Ethics Committee of Hasan Sadikin General Hospital, Bandung.
Results
During the two-year study period, there were 454 inpatients and 1,750 outpatients with the diagnosis of TB. The laboratory data showed 251 MTB cultures and 722 GeneXpert MTB results were positive. Of these, only 70 children underwent both GeneXpert MTB and MTB culture tests. The general characteristics of subjects are shown in Table 1 . The age group with the most TB cases was 10 to 18 years, and most of them were female (61.4%). Of the 70 subjects, most had well-nourished nutritional status (64.3%).
The factors that were associated with positive GeneXpert MTB results are listed in Table 2 . Factors with P value less than 0.25 were entered into the logistic regression model shown in Table 3 . From three factors associated with GeneXpert test, age 10 to 18 years had the strongest association.
There were 22 positive GeneXpert results and 19 positive culture results ( 
Discussion
Microbiological confirmation of childhood TB with culture is rarely performed and clinical diagnosis depends on a combination of signs, symptoms, radiological results, and identification of TB contact. 4 Culture is the gold standard for microbiological confirmation, but it takes 2 to 8 weeks to yield results. 14 In our study, we compared GeneXpert MTB test to cultures as the gold standard to detect MTB from respiratory specimens. There were 251 children who underwent MTB culture and 722 children who underwent GeneXpert MTB testing according to Clinical Pathology Laboratory and MDR TB outpatient data. However, only 70 children underwent both tests. The proportion of positive GeneXpert test (31.4%) was higher than in a previous South African study. 6 A negative GeneXpert test result did not necessarily exclude a TB diagnosis, given the fact that the test was unable to identify 27% of children with culture-confirmed tuberculosis. A clinical decision in the context of the patient, therefore, is important in initiating anti-tuberculosis therapy even for children with negative GeneXpert MTB test results. 7 The GeneXpert MTB assay performance has been previously evaluated mostly on sputum samples collected from adult TB patients, showing a high sensitivity in smear and culture-positive specimens (98-100%), but a much lower sensitivity in smearnegative sputum specimens (43-70%). 15, 16 Few such studies have been conducted in children. Nicol et al. showed an incremental increase in sensitivity of 27.8% for GeneXpert MTB, with specificity of 98.8%.6 Bunyasi et al. showed low sensitivity (26.7% for induced sputum samples and 22.6% for gastric lavage samples) and high specificity (100% for induced sputum samples and 99.6% for gastric lavage samples). 17 Our study showed that the GeneXpert MTB assay had 78.9% sensitivity (95%CI 56.7 to 91.5) and 86.3% specificity (95%CI 74.3 to 93.2). The Kappa value was k=0.62, indicating a good level of agreement. 12, 13 Other studies also reported good agreement between GeneXpert MTB and cultures. Tang et al. showed a Kappa value of 0.73, in their study of both adults and children. 18 Hasan et al. showed very good agreement (Kappa values >0.8), but with stool specimens, 19 and Li et al. showed a Kappa value of 0.6 for extrapulmonary TB. 20 We assessed what factors were associated with GeneXpert MTB test in predicting which children were likely to have positive results. Age (10 to 18 years), female sex, and positive tuberculin skin test (TST) were associated with positive GeneXpert MTB results. Primary infection during adolescence was associated with a high risk of developing adult-type disease. Adulttype disease results from primary infection, endogenous reactivation, or exogenous reinfection. Adult-type disease was most common after recent primary infection in children over 10 years of age. 21 Sekadde et al. reported that age >5 years, positive TST, and positive history of TB contact were independently associated with positive Xpert MTB/RIF test results. 7 Teenagers, especially girls in menarche period, have the highest risk of having tuberculosis after the primary infection during adolescence. 21 Marais et al. showed that adolescent girs were at higher risk of developing tuberculosis after recent primary infection than were boys. 22 Also, unlike younger children who get paucibacillary primary disease, older children, especially those above 10 years of age, are more likely to get reactivation/cavitatory disease, thereby increasing the likelihood of a positive GeneXpert MTB test. Moreover, a positive TST response is a marker of TB exposure and increases the likelihood of TB in a child with suspected pulmonary TB. 7 This study had some limitations. The data were taken from medical records, but some medical records were incomplete, so they were excluded. Also, this study was conducted only at a 3 rd level referral hospital, so we could not generalize to lower service level conditions.
In conclusion, the specificity (86.3%) of Gen-eXpert MTB is higher than the sensitivity (78.9%), compared to TB culture results in children. GeneXpert MTB and cultures had good accuracy and agreement. The factor most strongly correlated to positive GeneXpert MTB results is age 10 to 18 years.
